| Literature DB >> 28149652 |
Charles A Odonkor1, Teresa Tang1, David Taftian1, Akhil Chhatre2.
Abstract
Introduction. Cervicogenic headache is characterized by unilateral neck or face pain referred from various structures such as the cervical joints and intervertebral disks. A recent study of patients with cervical pain showed significant pain relief after cervical medial branch neurotomy but excluded patients with C1-2 joint pain. It remains unclear whether targeting this joint has potential for symptomatic relief. To address this issue, we present a case report of C1-2 joint ablation with positive outcomes. Case Presentation. A 27-year-old female presented with worsening cervicogenic headache. Her pain was 9/10 by visual analog scale (VAS) and described as cramping and aching. Pain was localized suboccipitally with radiation to her jaw and posterior neck, worse on the right. Associated symptoms included clicking of her temporomandibular joint, neck stiffness, bilateral headaches with periorbital pain, numbness, and tingling. History, physical exam, and diagnostic studies indicated localization to the C1-2 joint with 80% decrease in pain after C1-2 diagnostic blocks. She underwent bilateral intra-articular radiofrequency ablation of the C1-C2 joint. Follow-up at 2, 4, 8, and 12 weeks showed improved function and pain relief with peak results at 12 weeks. Conclusion. Clinicians may consider C1-C2 joint ablation as a viable long-term treatment option for cervicogenic headaches.Entities:
Year: 2017 PMID: 28149652 PMCID: PMC5253167 DOI: 10.1155/2017/1483279
Source DB: PubMed Journal: Case Rep Anesthesiol ISSN: 2090-6390
Figure 1(a) MRI of the cervical spine showed degenerative changes observed at C2 (thin arrow). Multilevel disc desiccation at C2–C5 without disc height loss; C2-C3 and C3-C4 disc bulge with uncovertebral joint hypertrophy and spinal canal stenosis (fat arrows) were noted. (b) Open-mouth view of atlantoaxial joint confirmed bilateral intra-articular RFN needle placement (arrows) into the AA joint.
Figure 2(a) Changes in visual analog pain score before procedure, and up to 12 weeks after procedure. (b) Changes in neck disability index, given as a percentage, before procedure and up to 12 weeks after procedure. A decrease of 10% from baseline score was used as an indicator of treatment success.
Figure 3SF-36 scores in quality of life measures, before procedure and up to 12 weeks after procedure. A 50% improvement from baseline scores was used as an indicator of treatment success.